Entrada Therapeutics Inc
Entrada Therapeutics Inc (TRDA) Option Chain
As of October 1, 2026, Entrada Therapeutics Inc is trading at $5.42, a -4.67% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 204.5%. IV Rank is 66%.
Read more
Tracking the TRDA option chain helps you see every strike and expiry on Entrada Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Entrada Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of TRDA options activity at a glance. Use our scanner to monitor the TRDA option chain in real time and filter for the TRDA options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For TRDA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the TRDA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where TRDA stock options are being actively traded and where they are not.
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc.
in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Entrada Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen TRDA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of TRDA stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile70.63% Elevated
- Market cap (M$)221
- 52 weeks high-65.47%
- 52 weeks low2.34%
- Analyst recommendationStrong Buy
1.29 - Target price$17.00
213.94% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-3.97
- EPS growth next 5 years4.81%
As of October 1, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 3.60 | 4 | 0 | 0.58 | 2.92 | 1.50 | 5.50 | 2.50 | -55.99 | — | 4.90 | 0.00 | 4.90 | 0 | 0 | 96.40 |
| 45.64 | 0 | 0 | 4.48 | 0.42 | — | 4.90 | 5.00 | -11.97 | — | 4.90 | 0.00 | 4.90 | 0 | 0 | 54.37 |
| 81.02 | 0 | 0 | 4.90 | 0.00 | — | 4.90 | 7.50 | +32.04 | — | 4.90 | 2.08 | 2.82 | 0 | 0 | 18.98 |
| 94.29 | 0 | 0 | 1.00 | 0.00 | — | 1.00 | 10.00 | +76.06 | 2.00 | 6.20 | 4.58 | -0.48 | 0 | 0 | 5.71 |
| 98.32 | 0 | 0 | 4.90 | 0.00 | — | 4.90 | 12.50 | +120.07 | 4.50 | 8.70 | 7.08 | -0.48 | 0 | 0 | 1.68 |
As of October 1, 2026
Scan the full option chain in one place
Browse the full TRDA option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→